Sign Out
Use in Pregnancy: There are no or limited amount of data from the use of Affinity-purified antibodies to human interferon gamma (Anaferon) in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive/foetal toxicity. As a precautionary measure, it is preferable to avoid the use of Affinity-purified antibodies to human interferon gamma (Anaferon) during pregnancy.
Use in Lactation: It is unknown whether Affinity-purified antibodies to human interferon gamma (Anaferon) and/or its metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded. Affinity purified antibodies to human interferon gamma (Anaferon) should not be used during breast-feeding.
Continue with Google